Nuntium

Excitando nuntium | Jymed Secures DMF Fines pro Quinque New Products in US
by admin on 25-03-25
Nuper, Shenzhen JMYMED Technology Co., Ltd. (Hereñafter Referred to as "JMED") habet feliciter complebitur medicamento Magister File (DMF et Drug / FDA products cum US Cibum et Drix Administration Portfolio), Praeterea expanding eius productum Portfolio. De jymmed jymmed est ...
Read More
Jymed invitationes ad Pchi MMXXV in Guangzhou
by admin on 25-02-21
Jymmed sincere invitat vos adiungere nobis ad MMXXV Pchi medicamine Ingredients in Guangzhou explorarent tardus foro trends, innovative technologiae et internationalis ordinationes. Visita nos in umbraculum 6j07! In MMXXV Guan ...
Read More
Excitando nuntium | Jymed scriptor peptide productio facilitas recipit WC Certification
by admin on 25-01-10
Nuper, Jymmed scriptor Peptide productio facilitas, Hubei Jianxiang Biopharmaceutical Co., Ltd., accepit duo officialis documenta edita a Hubei provinciarum medicamentis Administration, et No. GMP 2024-260 EC 2024-258 et E GMP 2024-260
Read More
Excitando nuntium | Sinis scriptor maximae semaglutide API productio facilitas transit US FDA inspectionem
by admin on 24-12-11
A Augusti XXVI ad August XXX, MMXXIV, jymmed scriptor peptide productio facilitas, Hubei Jx bio-pharmaceutical Co., Ltd., feliciter Transierunt an on-site inspectionem conducted per US cibum et medicamento administratione (FDA). Et inspectionem operuit key areas ...
Read More
MMXXIV CPHI Mediolanum PHARMACEUTICICUS Exhibition Recap
by admin on 24-10-18
I. Pre se ferre Overview on October 8th, in MMXXIV CPHI Worldwide Pharmaceutical Exhibitionem calce off in Mediolanum. Sicut unum ex maxime momenti annua certe in global pharmaceutical industria, quod attracted participantium ex CLXVI terris et regiones. Et super ...
Read More
Excitando nuntium | Jymed scriptor Liraglutide API accipit WC Certification
by admin on 24-10-17
Octobris XII, MMXXIV, Jymmed est Liraglutide API adeptus est scriptum confirmationis (WC) certificatorium, pretium est discrimine gradus ad prospere export de API ad EU foro. Et WC (Written Confirmationis) ...
Read More
Excitando nuntium: Jymmed Leuprorelin Acetate transit registration inspectionem
by admin on 24-08-29
Nuper, JMYMUS Technology Co., Ltd. nuntiatum est Leuprorelin acetate, produci per eius subsidiary Hubei Jx bio-pharmaceutical Co., Ltd., feliciter Transierunt medicamento adnotatione inspectionem. Original medicamento Market ...
Read More
Congratutlation JMED scriptor Tirzepatide Completus US-DMF interponere
by admin on 24-08-12
JYMed Technology Co., Ltd. is pleased to announce that its product, Tirzepatide, has successfully completed the Drug Master File (DMF) registration with the US FDA (DMF Number: 040115) and received the FDA's Acknowl...
Read More
Jymed attenditur Pct MMXXIV in Shanghai
by admin on 24-07-29
PCT2024 Personal Care Technology Summit & Pre se ferre est a valde gravis res in Asia-Pacific regione, focusing in technology commutationem et exhibitions in personalis cura products industry.The et operimentum variis rationibus personalis cura industry, inter technological in ...
Read More
Jymmed peptide invitationes ad adtende MMXXIV Korea in-stibio Ingredientia Exhibition
by admin on 24-07-16
Location: Korea Internationalis Pre se ferre Center Date: July 24-26, MMXXIV Time: 10:00 AM - 5:00 PM Address: Coex DXIII, Gangnam, Group Ingredien (VI) CLXIV in-Care Ingradien ...
Read More
Novum ordinacionem bulletin
by admin on 24-07-13
I. Nova FDA adnotatione ordinationes pro US COLORIUM COLOR sine FDA adnotatione erit interdictum a sale.According ad modernization of Cosmetics ordinacione actum de MMXXII, Signed by Praeses Biden in Foederatae Civitatibus Foederatae esse FDA, Registere ...
Read More
Spring tribuisti feriae notitiam
by admin on 24-02-01
Quaeso misericordiam informari, quod noster officium erit clausit ex Febr IV ad Feb.18 debitum ad fontem festival. Quis ordines non accepit sed non processionaliter usque ad Feb.19, primo negotio die post Fontem festival. Nos paenitet incommodum fecit.
Read More
MMXXIII ad 88th API Sina
by admin on 23-04-19
Notitia de jymmed ad MMXXIII API Sina 【De-Site】 sub ducibus de Vice Generalis procurator Zhi Qin, Shenzhen JMED Technology Co., Ltd. (Hereinafter referred to as jymmed) participatur in hoc spectacula. Jymmed Showcased Forsile products semaglutide, Liraglutide, Tirzepatide, O ...
Read More
Welcome to Occursum Nobis API Pre se ferre a QIindao Sinis Jymmed Stock: N4k32
by admin on 23-04-10

Read More
Jymed got una cum PCHI
by admin on 23-04-10
Post duos annos expectationem, in MMXXIII Sinis International Cosmetics personalis et Home Care rudis materiae se ferre (PGHI) erat tenuit in Guangzhou PAGUS Fair Complex Februarii 15-17, MMXXIII.
Read More
Semeglutide API Shenzhen jymmed accepit a primo batch de domesticis NMPA et descripserunt in US FDA (DMF No. (XXXVI) IX) cum status "a".
by admin on 23-02-17
In May MMXXII, Shenzhen JMYMED Technology Co., Ltd. (Hereñafter Referred to as jmed peptide) Submitted in US Cibum ad Registration SEMAGLUTIDE API ad US Food and Drix Administration (FDA API ad US Cibum et Drix Administration (FDA) (DMF Registration Administration (FDA I (DMF Registration Number: (XXXVI) PRINCIPIUM PRINCIPIUM PRINCTIRDATIONE Number: (FDA PRINCIPIUM PRINCIPIUM PRINCTIRDATION (FDA IT PRINCIPIUM PRINCIPIUM Number: et Hodiern
Read More
Aeris Peptides, cutis et capillos cura utilitates et quomodo ad eos
by admin on 22-09-08
Nos includit products quod cogitamus nostra legentibus invenies utile. Non potest earn parva commissione, si facere emptio per vinculum in hac pagina. Hoc est processus. Peptides sunt naturaliter occurrentes amino acida quod auxilium producere collagen et Elastin, duo nota textuum responsible pro s ...
Read More
Ozempic (semaglutide) iniectio: utitur, latus effectus, dosis
by admin on 22-09-08
Erica PROTY, pharmd, est professional pharmacopola assistentes aegris cum medicamento et pharmacy servicia in North Adams, Massachusetts. In non-humanae animal studia, semaglutide est ostensum est causa c cell thyroideum tumores in talpas. Tamen est obscura an hoc periculum se extendit ad homines ....
Read More
Derivatization adipem acida in inventionis et peptide et dapibus medicinae
by admin on 22-09-08
Tibi gratias ago pro visitare nature.com. Et pasco versio vos es usura habet limited css firmamentum. Nam optimum experientia, nos suadeo ut vos utor an updated pasco (vel inactivare compatibility modus in Penitus Rimor). In interim, ut continua firmamentum, ut non reddendis site sine s ...
Read More
Genus ego innovative pharmacum de jymmed fecerunt significant profectum, laiphutai expectat ut facti primus linea UC medicinae.
by admin on 19-03-02
De June XXIX, MMXVII, in progressionem LaiphiTai, in genus ego innovative medicina cum cooperantem progressionem de jymmed et Guangzhou Life Medical Technology Co., Ltd, fecit significant progressus. De medicamento scriptor Ind declarationem accepit a CFDA. Jymed et Guangzhou Lin ...
Read More